Results 301 to 310 of about 2,421,996 (355)

4D Mapping of ZIF Biocomposites for High Protein Loading and Tunable Release Profiles

Advanced Functional Materials, EarlyView.
Systematic four‐dimensional mapping of zeolitic imidazolate framework biocomposites reveals how precursor ratios, total concentration, and washing define crystalline phase, protein loading, and release kinetics. This comprehensive study identifies conditions yielding record loading (∼85%) and precise phase–property correlations.
Michael R. Hafner, Francesco Carraro, Behnaz Abbasgholi‐NA, Simone Dal Zilio, Max Schmallegger, Helmar Wiltsche, Lingcong Ge, Michael R. Reithofer, Efwita Astria, Laura Villanova, Heinz Amenitsch, Christian Doonan, Paolo Falcaro   +12 more
wiley   +1 more source

Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease. [PDF]

Tuberc Respir Dis (Seoul)
Kang HK, Choi SM, Shin HJ, Jung HI, An U, Yang SH.   +5 more
europepmc   +1 more source

Causality between aging and interstitial lung disease: A bidirectional two-sample Mendelian randomization study. [PDF]

J Int Med Res
Luo W, Tang X, Zhou X, Liu Y, Yuan C, Li W, Xia Y, Su S, Qian C, Li Z, Li K, Shang L, Wang Z, Xiang Y, Ruan Z, Wang T.   +15 more
europepmc   +1 more source

A dataset of lung ultrasound images for automated AI-based lung disease classification. [PDF]

Data Brief
Katumba A, Murindanyi S, Okila N, Nakatumba-Nabende J, Mwikirize C, Serugunda J, Bugeza S, Oriekot A, Bossa J, Nabawanuka E.   +9 more
europepmc   +1 more source

Thoracic ultrasound in interstitial lung disease. [PDF]

Breathe (Sheff)
Shah DJ, Esposito A, Pitaktong A, Sauthoff H.   +3 more
europepmc   +1 more source

Intratracheal instillation of corticosteroids combined with surfactant for preventing chronic lung disease in preterm infants. [PDF]

Cochrane Database Syst Rev
Bolanos L, Borys F, Pahl A, Fiander M, Cracknell J, Gautham KS, Soll RF, Bruschettini M, supported by Cochrane Sweden and Cochrane Neonatal.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mild parenchymal lung disease is still lung disease

European Respiratory Journal, 2020
PAH patients with mild parenchymal disease/low DLCO should be considered as group 3 patients with pulmonary vascular phenotypehttps://bit.ly ...
Joan Albert Barberà, Laurent Godinas, Sergio Harari, David Montani, David Montani   +4 more
openaire   +7 more sources

Eosinophilic Lung Disease

Immunology and Allergy Clinics of North America, 2008
Eosinophilic lung diseases comprise eosinophilic pneumonia, which may present with chronic or acute onset, or as Löffler syndrome. The diagnosis of eosinophilic pneumonia relies on clinical imaging and the demonstration of alveolar eosinophilia. Lung biopsy is generally not necessary.
Cottin, Vincent, Cordier, Jean-François
openaire   +7 more sources

Interstitial lung disease

Current Opinion in Rheumatology, 2012
Pulmonary fibrosis is a devastating disease that affects millions of people worldwide. Among the most common forms of lung fibrosis are idiopathic pulmonary fibrosis (IPF) and scleroderma-related interstitial lung disease (SSc-ILD). Despite a wealth of literature regarding each of these diseases, studies that directly compare IPF and SSc-ILD are rare ...
Erica L. Herzog, Lynne Murray, Ami N. Rubinowitz   +2 more
openaire   +3 more sources